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Abstract
Mice genetically deficient in growth and differentiation factor 8 (GDF8/myostatin) had markedly increased muscle fiber
numbers and fiber hypertrophy. In the regenerating muscle of mice possessing FGF6 mutation, fiber remodeling was
delayed. Although myostatin and FGF6 may be important for the maintenance, regeneration and/or hypertrophy of muscle,
little work has been done on the possible role of these proteins in adult muscle in vivo. Using Western blot and
immunohistochemical analysis, we investigated, in rats, the distribution of myostatin, FGF6 and LIF proteins between slow-
and fast-type muscles, and the adaptive response of these proteins in mechanically overloaded muscles, in regenerating
muscles following bupivacaine injection and in denervated muscles after section of the sciatic nerve. The amounts of
myostatin and LIF protein were markedly greater in normal slow-type muscles. In the soleus muscle, myostatin and LIF
proteins were detected at the site of the myonucleus in both slow-twitch and fast-twitch fibers. In contrast, FGF6 protein was
selectively expressed in normal fast-type muscles. Mechanical overloading rapidly enhanced the myostatin and LIF but not
FGF6 protein level. In the regenerating muscles, marked diminution of myostatin and FGF6 was observed besides
enhancement of LIF. Denervation of fast-type muscles rapidly increased the LIF, but decreased the FGF6 expression.
Therefore, the increased expressions of myostatin and LIF play an important role in muscle hypertrophy following
mechanical overloading. The marked reduction of FGF6 in the hypertrophied and regenerating muscle would imply that
FGF6 regulates muscle differentiation but not proliferation of satellite cells and/or myoblasts. ß 2000 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Skeletal muscle satellite cells are normally found in
a quiescent state in adult muscle, but when minor
damage or injury occurs, signals are generated within
the muscle that activate the satellite cells, stimulating
them to migrate and enter the cell cycle. Activated
satellite cells have been shown to migrate to the site
of an injury where they proliferate, di¡erentiate, and
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fuse with the damaged ¢ber or form new ¢bers [1]. In
vitro studies have documented many factors, primar-
ily protein growth factors, that can modulate satellite
cell activity [1]. In particular, insulin-like growth fac-
tor I (IGF-I), known to be up-regulated both in hy-
pertrophied and regenerating muscle in vivo [2,3],
positively regulated the proliferation and di¡erentia-
tion of satellite cells and myoblasts in vitro [4]. In the
transgenic mouse, Coleman et al. found that over-
expression (47-fold increase) of IGF-I in muscle leads
to hypertrophy of muscles, but not of other tissues
[5]. On the other hand, newborn mice homozygous
for a targeted disruption of IGF-I exhibit growth
de¢ciency and marked hypoplasia [6]. Furthermore,
IGF-I seems to promote myotube hypertrophy by
signal transduction via calcineurin association with
a nuclear factor of activated T-cells (NFATc1) and
GATA2 [7,8]. Therefore, IGF-I is generally consid-
ered the positive regulator of muscle mass.
Bone morphogenetic protein (BMP2), transform-
ing growth factor-L2 (TGF-L2) and basic ¢broblast
growth factor (bFGF) inhibit the terminal di¡eren-
tiation of myogenic cells into mature muscle cells [9^
11]. However, inactivation of TGF-L1, TGF-L2,
TGF-L3, leukemia inhibitory factor (LIF), platelet-
derived growth factor (PDGF) and FGF, which all
have proven activities on skeletal muscle tissue in
vivo or cultured muscle cells in vitro, had no overt
e¡ects on normal muscle cell development or muscle
physiology [12^15], although the mRNA and protein
of bFGF, TGF-L2 and LIF were markedly elevated
in hypertrophied and regenerating muscle [16^19].
Recently, many researchers have been very inter-
ested in other growth factors, such as growth and
di¡erentiation factor 8 (GDF8)/myostatin and ¢bro-
blast growth factor 6 (FGF6), belonging to the TGF-
L superfamily and FGF family, respectively. During
the early stages of embryogenesis, the expression of
these factors is restricted to the myotome compart-
ment of developing somites [20,21]. In later stages
and in adult animals, myostatin is expressed in
many di¡erent muscles throughout the body [21]. A
null mutation of myostatin markedly increased
muscle ¢ber numbers and elicited ¢ber hypertrophy
[21,22]. Although mice genetically de¢cient in FGF6
had no overt symptoms on normal muscle develop-
ment or muscle physiology [23], they showed a severe
regeneration defect with ¢brosis and myotube degen-
eration due to a lack of activation or proliferation of
satellite cells [24]. Since it seems that myostatin and
FGF6 are important in the maintenance of muscle
morphology, it is worth investigating the role and
manner of change in these growth factors in regen-
erating, hypertrophied and denervated muscle in
vivo.
In the present study, using Western blot analysis
and immunohistochemistry, we examined the normal
distribution of myostatin, FGF6 and LIF and the
adaptive response of these factors in mechanically
overloaded, regenerating and denervated muscles.
2. Materials and methods
2.1. Animals and experimental procedures
2.1.1. Animals
Male (n = 36, 10 and 20 weeks of age) and female
(n = 48, 12 weeks of age) Wistar rats were used in the
experiments. The rats were housed in a temperature
(22 þ 2‡C) and humidity (60 þ 5%)-controlled room
regulated to provide alternating 12-h periods of light
and darkness. They were allowed to feed (commer-
cial rat chow) and drink ad libitum. Rats of both
sexes were used for the experiments because no dif-
ference between male and female rats with regard to
the level of myostatin, FGF6 and LIF proteins, was
found in our preliminary study.
2.1.2. Normal adult muscles and organs
Three male Wistar rats (20 weeks of age) were
used in this experiment. Rats were killed using excess
pentobarbital administration, and brain, cerebellum,
spinal cord, muscle, heart, liver, kidney, stomach,
lung, testis and thymus were rapidly dissected. To
compare the amount of myostatin, FGF6 and LIF
proteins among several di¡erent muscles, six male
Wistar rats (10 weeks of age) with body weights of
300^350 g were used. Rats were killed using excess
pentobarbital administration, and extensor digitorum
longus, tibialis anterior, gastrocnemius, soleus and
diaphragm muscles were rapidly dissected.
2.1.3. Overloading
Twenty-seven adult female Wistar rats (12 weeks
of age) with body weights of 200^250 g were used in
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this experiment. Compensatory enlargement of the
plantaris muscle was induced in one leg of each rat
by surgical removal of the ipsilateral soleus and gas-
trocnemius muscles as described previously [18].
While the rat was under pentobarbital anesthesia
(50 mg/kg i.p.), an incision was made through the
skin and fascia on the caudal aspect of the leg over
the calf musculature. The tendons of the soleus and
the lateral and medial heads of the gastrocnemius
muscle were exposed and severed, and the muscles
were carefully peeled up and away from the intact
plantaris muscle. Care was taken to avoid rupturing
vessels and nerves, and bleeding in the surgical ¢eld
was minimal. The soleus muscle and the two heads of
gastrocnemius muscle were then clamped o¡ with a
hemostat near their origins and ablated. The wound
was cleansed, and the fascia and skin were then su-
tured with surgical silk. A sham operation was per-
formed on the contralateral leg after the rat was
anesthetized by i.p. injection of sodium pentobarbi-
tal. All rats awoke from anesthesia within 2 h, and
were observed to use both hindlimbs immediately.
Rats were killed, in groups of three, using excess
pentobarbital administration, and the plantaris
muscle of both legs dissected at 1, 2, 3, 4, 6, 8 and
10 days and 2 and 4 weeks postsurgery.
2.1.4. Bupivacaine treatment
Twenty-seven adult male Wistar rats (10 weeks of
age) with body weights of 270^360 g were used in
this experiment. While under pentobarbital anesthe-
sia (50 mg/kg, i.p.), the rat received an i.m. injection
of 0.5 ml of 0.5% bupivacaine hydrochloride in 0.9%
saline into the TA muscle on one side as described
previously [19]. The morphological change of skeletal
muscle following bupivacaine injection was clearly
demonstrated by the study of Hall-Craggs [25]. After
1 day, ¢bers were reduced caliber, rounded in out-
line, and widely separated from each other. Between
the ¢bers were extravagation of red blood cells and a
leukocyte in¢ltration. At 3 days, some ¢bers had
been invaded by macrophages but many had become
so completely disorganized that it was no longer pos-
sible to distinguish between myonuclei and in¢ltrat-
ing cells. At 3 weeks, many ¢bers had regained a
normal caliber although the vast majority still had
centrally placed nuclei. Rats were killed, using excess
pentobarbital administration, in groups of three at
the same time point used in the overloading experi-
ment. The TA muscles of both legs were dissected.
2.1.5. Denervation
Twenty-one adult female Wistar rats (12 weeks of
age) with body weights of 200^240 g were used in the
experiment. The left sciatic nerve was cut at mid
thigh and a 1-cm length of nerve resected as de-
scribed previously [26]. Denervation induce a marked
atrophy of muscle ¢ber, increase the connective tis-
sue in muscle and markedly promoted the transfor-
mation from type I to type II ¢bers in the case of
soleus muscle [26]. Using excess pentobarbital ad-
ministration, rats were killed in groups of three at
1, 2, 4, 7 and 10 days and 2 and 4 weeks postsurgery.
The soleus, plantaris and gastrocnemius muscles of
both legs were dissected.
2.2. Primary antibodies
A⁄nity-puri¢ed goat polyclonal antibody to
GDF8/myostatin (1:260, C-20, Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), a⁄nity-puri¢ed goat
polyclonal antibody to FGF6 (1:260, C-19, Santa
Cruz Biotechnology), and a⁄nity-puri¢ed goat poly-
clonal antibody to LIF (1:400, N-18, Santa Cruz
Biotechnology) were used in this study.
2.3. Tissue preparation, gel electrophoresis and
immunoblots
Tissue from each muscle was homogenized in 10^
20 vols. 50 mM Tris^HCl pH 7.4, 5 mM EDTA, 10
Wg/ml phenylmethylsulfonyl£uoride, 0.5 Wg/ml leu-
peptin, 0.2 Wg/ml aprotinin, 0.2% NP-40, 0.1% Triton
X-100, 0.05% mercaptoethanol, 1 mM Na3VO4 in a
polytron (PCU-2, Kinematica, Steinhofhalde, Swit-
zerland) for 30 s. The supernatant obtained after
centrifugation of a homogenized tissue at 15 000Ug
for 25 min (4‡C) was designated the homogenate,
and the protein concentration of the homogenate
determined colorimetrically (Bio-Rad protein deter-
mination kit, Bio-Rad, Richmond, CA). Sodium
dodecylsulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) (12.5% acrylamide) was performed ac-
cording to the method of Laemmli [27]. Proteins sep-
arated by SDS^PAGE were transferred electrophor-
etically onto nitrocellulose membranes (Hybond-
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ECL Western, Amersham, Arlington Heights, IL).
The blots were incubated with a blocking bu¡er of
0.1% Tween-20 and 1% gelatin in 10 mM Tris-bu¡-
ered saline (TBS, 10 mM Tris, 135 mM NaCl, 1 mM
KCl, 0.02% NaN3, pH 7.4) in cold room overnight.
The blots were incubated with the primary antibodies
for l h, and then incubated with biotinylated anti-
goat IgG (1:300, BA-5000, Vector Laboratories)
for l h. The blots were incubated for 30 min with
peroxidase streptavidin conjugate (Vector), and visu-
alized with diaminobenzidine (DAB) and H2O2.
2.4. Immunohistochemistry
Serial 8-Wm transverse sections made with a cryo-
stat (Bright 5030 Microtome, Bright Instrument,
Huntingdon, Cambridgeshire, UK) were mounted
on silanized slides (Dako Japan, Tokyo). All subse-
quent steps are as described previously [19]. Brie£y,
the sections were incubated with primary antibodies
diluted in phosphate-bu¡ered saline (PBS) for 60 min
at room temperature (RT). Sections were subse-
quently rinsed well with PBS, and incubated with
biotinylated anti-goat IgG (1:500 dilution, Vector)
for 30 min at RT. After extensive rinsing, sections
were incubated for 30 min with peroxidase strepta-
vidin conjugate (Vector), and visualized with DAB
and H2O2. The sections were mounted in a glycer-
ol-based medium containing p-phenylenediamine.
Negative control slides with omission of the primary
antibodies were included in the immunostaining pro-
cedures in each instance.
2.5. Histochemistry
To clarify each ¢ber as slow-twitch oxidative (SO),
fast-twitch oxidative glycolytic (FOG) or fast-twitch
glycolytic (FG) according to Peter et al. [28], succes-
sive cryosections were stained for myo¢brillar acto-
myosin adenosine triphosphatase (mATPase) after
preincubation pH 10.3 [29] and for nicotinamide ad-
enine dinucleotide tetrazolium reductase (NADH-
TR).
3. Results
Using Northern blot analysis, McPherron et al.
[21] reported that, in the adult mouse, skeletal
muscles possess selective myostatin mRNA. Under
Fig. 1. Western blot analysis of myostatin and FGF6 in extracts of various organs from normal adult rats (20 weeks old). (A) Myo-
statin selectively existed in skeletal muscle. (B) FGF6 protein existed in skeletal muscle, heart and kidney. Immunoblotting with anti-
bodies to myostatin and FGF6 revealed prominent bands consistent with a molecular size of 26 kDa and 38^40 kDa, respectively.
Proteins (12 Wg in 8-Wl aliquots) were subjected to SDS^PAGE, followed by Western blotting. Proteins transferred to the nitrocellulose
sheet were stained with antibodies against myostatin or FGF6 and visualized with diaminobenzidine.
BBAMCR 14632 22-5-00
K. Sakuma et al. / Biochimica et Biophysica Acta 1497 (2000) 77^8880
reducing conditions, in Chinese hamster ovary
(CHO) cells, mature myostatin was expressed as a
15-kDa protein. However, as shown in Fig. 1A, im-
munoblotting with antibodies to myostatin revealed
prominent bands consistent with a molecular size of
26 kDa. This result is in complete agreement with the
¢nding of Gonzalez-Cadavid et al. [30], which
showed that myostatin is expressed in the human
skeletal muscle as a 26-kDa mature glycoprotein
and secreted into the plasma. As pointed out by
Gonzalez-Cadavid et al. [30], the discrepancy in the
apparent molecular masses between the previous re-
port and our experiment appears to be caused by
glycosylation 26-kDa band in the human and rat
muscles as opposed to CHO cells, as in the case for
TGF-L receptor, inhibin and activin [31]. Myostatin
protein was detected in the skeletal muscle (soleus),
but not other organs, such as the brain, spinal cord,
heart, liver, kidneys and thymus.
It has been demonstrated that, in the adult mouse,
FGF-6 mRNA was detected in the skeletal muscle,
heart and testes [20]. At the protein level, the expres-
sion of FGF6 was detected in the skeletal muscle,
heart and kidneys of adult rats at an approximate
molecular weight of 38^40 kDa (Fig. 1B).
The manner of myostatin expression in muscle is
di¡erent between humans and mice [30,32]. The dis-
tribution patterns of FGF6 and LIF proteins in dif-
ferent muscles are unknown except for the ¢ndings in
trout [33]. We determined whether, in normal adult
rats, myostatin, FGF6 and LIF protein content dif-
fers between slow-type muscles (soleus) and fast-type
muscles (extensor digitorum longus, tibialis anterior,
gastrocnemius and diaphragm). Western blot analy-
sis showed that the myostatin level was markedly
higher in the slow-type than in the fast-type muscles
(Fig. 2, upper panel). On the other hand, preferential
accumulation of the FGF6 protein was observed in
the fast-type muscles (Fig. 2, middle panel) similar to
the distribution pattern of trout muscle. No detection
of LIF protein in normal fast-type rat muscle (Fig. 2,
lower panel) is consistent with the ¢nding of Kurek
et al. [16,34]. However, LIF protein was normally
present in the slow-type rat muscle (Fig. 2, lower
panel).
To understand more clearly the cellular localiza-
tion of myostatin, FGF6 and LIF, we performed
immunohistochemistry of transverse section of soleus
and tibialis anterior muscles of normal adult rats (20
weeks of age). In the soleus muscle, myostatin ex-
pression was markedly detected at the site of the
myonucleus of both slow-twitch and fast-twitch ¢-
bers (Fig. 3C,F), but not in the case of omitting
primary antibody (Fig. 3E). In contrast, some fast-
twitch oxidative glycolytic (FOG) ¢bers had slight
immunoreactivity of myostatin on the sarcolemma
of tibialis anterior muscle (Fig. 3D), although many
FOG and fast-twitch glycolytic (FG) ¢bers did not
possess myostatin.
As illustrated in Fig. 4, in the tibialis anterior
muscles of normal adult rats, slight immunoreactiv-
ities of LIF and FGF6 were observed on the sarco-
lemma of FOG ¢bers (Fig. 4C,E). On the other
hand, we found pronounced LIF immunoreactivity
on the sarcolemma and in the myonucleus of both
slow-twitch and fast-twitch ¢bers in the soleus
muscle (Fig. 4D). FGF6 expression was not detected
Fig. 2. Myostatin and LIF proteins are preferentially distrib-
uted in the slow-type muscle, whereas FGF6 protein is accumu-
lated in the fast-type muscles. Western blot analysis of myosta-
tin (upper panel), FGF6 (middle panel) and LIF (lower panel)
in extracts of slow- and fast-type muscles of normal adult rats
(10 weeks old). Immunoblotting with antibodies to LIF re-
vealed prominent bands consistent with a molecular size of 45
kDa.
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in the cytosol, sarcolemma and the extracellular
spaces in the soleus muscle ¢bers (Fig. 4F).
Overloading induced marked increases in the
weight of the plantaris muscles during the entire
postsurgical period (1 day to 4 weeks). The weight
after 1 day showed a 56.0% increase over the control
value. The percentages of hypertrophy after 3, 6 and
10 days were 40.9, 31.3 and 44.8%, respectively, and
BBAMCR 14632 22-5-00
K. Sakuma et al. / Biochimica et Biophysica Acta 1497 (2000) 77^8882
after 2 and 4 weeks were 46.8 and 76.2%, respec-
tively.
The functional signi¢cance of myostatin and
FGF6 in ¢ber hypertrophy of fully di¡erentiated
muscle is not known, although studies in mice with
null mutation myostatin suggested that myostatin is
negatively regulated hyperplasia and hypertrophy of
muscle ¢bers in myogenesis [21,22]. The patterns of
myostatin, FGF6 and LIF expression in the control
and mechanically overloaded plantaris muscles are
shown in Fig. 5. Compared to the unoperated plan-
taris muscle, mechanical overloading increased the
myostatin protein after 2 days of stimulation. As
demonstrated in our previous study using immuno-
histochemistry, mechanical overloading markedly en-
hanced LIF protein 2^14 days postsurgery compared
to the control level. In contrast, the slightly detected
FGF6 protein in non-stimulated muscle was clearly
diminished by mechanical overloading and restored
after 28 days of stimulation.
One and 2 days postinjection, the tibialis anterior
muscle increased in wet weight by 49.3% and 20.4%
over that of the control. Six, 8 and 10 days after
bupivacaine injection, the tibialis anterior wet weight
decreased 29.7, 20.2 and 13.8% under the control
value, respectively. Complete restoration of wet
weight was achieved after 28 days in tibialis anterior
muscles subjected to bupivacaine.
In mice with null mutation of the FGF6 and LIF
genes, muscle regeneration following damage was in-
complete [24,35]. No study has determined the role
of myostatin in muscle remodeling. As shown in Fig.
6, both myostatin and the FGF6 protein were
slightly detected in the unoperated tibialis anterior
muscle of rats. These growth factor levels rapidly
decreased in the regenerating muscle subjected to
bupivacaine-injection, and were restored 28 and 14
days postsurgery, respectively. Similar to mechani-
cally overloaded muscle, the LIF protein increased
in the regenerating muscle 2^14 days postsurgery.
Denervation induced marked decreases in the
weight of the soleus, plantaris and gastrocnemius
muscles. Seven days postsurgery, all the muscles
showed a decreased wet weight of about 73^80% of
the control value. Fourteen days after denervation,
the weight of the denervated muscles decreased to
58^63% of the control value and achieved 30^45%
of the control level 4 weeks postsurgery.
Although hindlimb unweighting, a model of
muscle inactivity, elevates myostatin mRNA in the
plantaris muscle [32,36], but not in the soleus muscle
[32], the in£uence on neuromuscular activity of my-
ostatin and FGF6 protein levels is unknown. In the
soleus muscle, gradual diminution of myostatin was
observed on denervation, whereas in the denervated
plantaris and gastrocnemius muscles, myostatin lev-
els slightly increased 4 and 28 days after denervation,
respectively (Fig. 7A). The FGF6 protein was not
detected in the soleus muscle of the normal intact
or denervated rats, and was gradually diminished in
the fast-type muscle subjected to denervation (Fig.
7B). In contrast to the soleus muscle, denervation
of the plantaris and gastrocnemius muscles markedly
elevated the LIF protein level (Fig. 7C), similar to
the results of Kurek et al. [33].
4. Discussion
Some recent studies [30,32] have reported the man-
ner of myostatin distribution between slow-type and
fast-type muscles. In human, myostatin was equally
distributed in the type I and II ¢bers [30]. In con-
trast, Carlson et al. [32] demonstrated, using North-
Fig. 3. Serial cryosections of the soleus (A, C, E and F) and tibialis anterior (B and D) muscles from normal adult rats. Each cryosec-
tion was stained for myo¢brillar actomyosin adenosine triphosphatase (mATPase) at alkaline pH (A), nicotinamide adenine dinucleo-
tide tetrazolium reductase (NADH-TR)(B) or immunohistochemically stained for the myostatin antibodies (C, D and F). In the soleus
muscle, myostatin immunoreactivity was detected at the site of myonucleus in both slow-twitch and fast-twitch ¢bers (C), but not in
the case of omitting primary antibody (E). Higher magni¢cation of the photograph clearly indicates the myostatin immunostaining of
the myonucleus (arrow) in the soleus muscle ¢bers (F). Primary antibodies were visualized by a standard avidin^biotin peroxidase
method. Scale bar: 50 Wm. In contrast, myostatin immunoreactivity was slightly detected on the sarcolemma of some fast-twitch oxi-
dative glycolytic (FOG) ¢bers in the tibialis anterior muscle (D). All ¢bers recognized in the photograph (B) were characterized by
fast-twitch (FT) by staining for mATPase at alkaline pH (data not shown). White circles denote the same ¢ber of di¡erent cryosection
(A, C and E).
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Fig. 4. Serial cryosections of tibialis anterior (A, C and E) and soleus (B, D and F) muscles from normal adult rats. Each cryosection
was stained for NADH-TR (A), for mATPase at alkaline pH (B), or immunohistochemically stained for the LIF (C and D) and
FGF6 (E and F) antibodies. In the tibialis anterior muscle, LIF and FGF6 were slightly detected on the sarcolemma of FOG ¢bers.
Primary antibodies were visualized by a standard avidin^biotin peroxidase method. Scale bar: 50 Wm. All ¢bers recognized in the pho-
tograph (A) were characterized by fast-twitch (FT) by staining for mATPase at alkaline pH (data not shown). In contrast, the myonu-
cleus and sarcolemma of both slow-twitch and fast-twitch ¢bers (arrow) of the soleus muscle were markedly stained for LIF antibod-
ies. FGF6 immunoreactivity was not detected in the soleus muscle ¢bers (F). White circles (A, C and E) and triangles (B and D)
denote the same ¢ber of di¡erent cryosection.
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ern blot analysis, that the expression of myostatin
was not detected in the slow-type soleus muscle
and was only selectively occurred in type IIB ¢bers
in mouse. However, the present study clearly showed
the preferential distribution of myostatin in the sol-
eus muscle. This may be ascribed to the greater
amount of several growth factors and the satellite
cells [37,38]. bFGF and LIF, potent regulators in
the proliferation of satellite cells and myoblasts in
vitro [39,40], are abundant in the slow-type muscle
[37]. Furthermore, bFGF and LIF were up-regulated
in the hypertrophied anterior latissimus dorsi (ALD)
muscle of the quail and in the hypertrophied planta-
ris muscle of the rat, respectively [17,18]. It seems
that, under normal conditions, mechanical stress pro-
duced by muscle contraction partially destroys the
sarcolemma of muscle ¢ber, and satellite cell activa-
tion is needed to complete the remodeling of dam-
aged ¢ber. Thus, myostatin may potently inhibit the
neo-formation of muscle ¢bers by the fusion of pro-
liferating satellite cells to each other by stimulating
bFGF, LIF, and the other growth factors in slow-
type muscle.
Recently, the major concerns of researchers have
been directed at how myostatin, a potent negative
regulator of muscle mass, acts in the hypertrophy
and regeneration of fully di¡erentiated adult muscle.
We were also interested in the adaptive response of
myostatin in muscles under these conditions. To our
knowledge, this investigation is the ¢rst study in
which myostatin increased in mechanically hypertro-
phied muscle. One possible interpretation of the en-
hancement is related to the inhibition of neo-forma-
tion of muscle ¢bers. Mechanical overloading does
not promote the formation of new muscle ¢bers in
Fig. 6. Bupivacaine injection enhances LIF protein and reduces
myostatin and FGF6 protein in tibialis anterior muscle. West-
ern blot analysis of myostatin (upper lane), FGF6 (middle lane)
and LIF (lower lane) in extracts of regenerating tibialis anterior
muscles.
Fig. 7. The adaptive changes in myostatin, FGF6 and LIF pro-
teins in slow- and fast-type muscles after denervation. (A)
Western blot analysis of myostatin in extracts from soleus
(upper lane), plantaris (middle lane) and gastrocnemius (lower
lane) muscles subjected to sciatic denervation. In the soleus
muscle, gradual diminution of myostatin was observed, whereas
in the denervated plantaris and gastrocnemius muscles, myosta-
tin levels slightly increased after 4 and 28 days of denervation,
respectively. (B) Western blot analysis of FGF6 in extracts of
plantaris (upper lane) and gastrocnemius (lower lane) muscles
subjected to denervation. FGF6 protein was gradually dimin-
ished in the fast-type muscle subjected to denervation. (C)
Western blot analysis of LIF in extracts of soleus (upper lane),
plantaris (middle lane) and gastrocnemius (lower lane) muscles
subjected to denervation. Denervation of the fast-type muscles,
but not slow-type muscle markedly elevated the LIF protein
level.
Fig. 5. Mechanical overloading increases expression of myosta-
tin and LIF proteins and diminishes FGF6 protein in the plan-
taris muscle. Western blot analysis of myostatin (upper lane),
FGF6 (middle lane) and LIF (lower lane) in extracts of planta-
ris muscles subjected to mechanical overloading.
BBAMCR 14632 22-5-00
K. Sakuma et al. / Biochimica et Biophysica Acta 1497 (2000) 77^88 85
the plantaris muscle [41], but seems to induce the
hypertrophy of originally existing muscle ¢bers by
enhancing DNA synthesis, which is expected to pre-
cede the fusion of the putative satellite cell nuclei
into the main body of the muscle ¢ber [42]. Dou-
ble-muscled animals, possessing myostatin muta-
tions, are characterized by an increase in muscle
mass of about 20% due to an increase in the number
of muscle ¢bers rather than in their individual diam-
eter [43]. On the other hand, a marked reduction in
myostatin was observed in regenerating muscle.
Muscle regeneration involves fusion of proliferating
satellite cells with each other to form young multi-
nucleated myotubes, as well as with the ends of ex-
isting damaged myo¢bers. In the early phase of
muscle regeneration, the hyperplasia-inhibiting role
of myostatin is unnecessary and the restoration of
the myostatin level 28 days postsurgery may be im-
portant in controlling the muscle ¢ber numbers.
Semsarian et al. [44] demonstrated, that in C2C12
cells, the myostatin transcript level did not alter in
hypertrophied myotubes transfected with IGF-I. The
real function of myostatin in muscle remodeling,
however, remains to be elucidated in further studies.
Denervation mildly enhanced myostatin protein
levels in the fast-type plantaris muscle, but not gas-
trocnemius muscle (Table 1). These results are con-
sistent with the ¢ndings of Wehling et al. [36] and
Carlson et al. [32], who found that hindlimb un-
weighting, the other model of inactivity, increased
myostatin mRNA in the plantaris muscle, as well
as causing mild atrophy of muscle ¢ber. In addition,
Gonzalez-Cadavid et al. [30] reported that myostatin
protein increased in the muscles of HIV-infected pa-
tients undergoing weight loss. Collectively, myostatin
may be an attenuator of skeletal muscle growth in
adult humans, rats and mice. However, our current
study showed that myostatin levels decreased in the
denervated slow-type rat muscle. Furthermore, hind-
limb suspension did not change the myostatin
mRNA level of the soleus muscle in mice [32]. My-
ostatin may have a di¡erent role in slow- and fast-
type muscles.
Mice with the null mutation of the FGF6 gene
show incomplete regeneration following injury, prob-
ably due to a marked reduction in the number of
MyoD- and myogenin-expressing satellite cells,
rather than a de¢ciency in the proliferation of satel-
lite cells [24]. This phenotype in the regenerating
muscle resembles mice with genetically de¢cient
MyoD [45]. Several recent studies implied that a
break in the integrity of the plasma membrane is
an essential element for muscle hypertrophy, because
chemical mediators (growth factors) of remodeling
stored in the cell cytosol (e.g. bFGF) are released
from this location through plasma membrane disrup-
tion [46,47]. If so, it seems that FGF6 has an impor-
tant role in the mechanically stressed muscle, includ-
ing the damage-regeneration (remodeling) phase.
Surprisingly, after bupivacaine injection and me-
chanical overloading of rat muscle, FGF6 protein
levels rapidly decreased similar to the changes in
MyoD family protein (MyoD, Myf-5 and myogenin)
under these conditions [48]. Although in vitro studies
showed that FGF6 at certain concentrations modu-
lated the proliferation and di¡erentiation of C2 cells
[49], it may not have the ability to induce the pro-
liferation of satellite cells in vivo muscle in contrast
to IGF-I, hepatocyte growth factor/scatter factor
(HGF/SF) and LIF. In the regenerating TA muscle,
muscle di¡erentiation including the formation of
multinucleated myotubes seems to proceed drasti-
cally between 3 and 6 days after bupivacaine injec-
tion using our method because of a rapid decrease in
TGF-L2, a potent inhibitor of muscle di¡erentiation
[11], and a marked increase inf MyoD during the
same period. In the di¡erentiation phase of C2 cells,
recombinant FGF6 delays the expression of MyoD.
MyoD induces permanent cell cycle arrest by up-reg-
ulating the cyclin-dependent kinase (cdk) inhibitor
p21 [50] and/or p300 [51] and activates muscle-spe-
Table 1
Summarization of the adaptive response of myostatin, FGF6
and LIF proteins in the muscles subjected to various operations
Myostatin FGF6 LIF
Mechanical overloading u ss uu
Bupivacaine injection ss ss uu
Denervation
Soleus s not detected ^
Plantaris u ss u
Gastrocnemius ^ ss uu
Changes in protein levels are indicated by: uu, marked in-
crease; u, increase; ss, marked decrease, s, decrease; ^, no
change compared with normal muscles. FGF6, ¢broblast
growth factor 6; LIF, leukemia inhibitory factor.
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ci¢c gene transcription in myogenesis. In the early
and later phases of remodeling in mechanically over-
loaded and regenerating muscles, a reduction in
FGF6 proteins seems very important in that growth
factors, cyclin-dependent kinase, cyclin D1 and the
E2F family, which regulate cell cycle progression,
stimulate the proliferation of satellite cells [52,53]
and the latter induce the di¡erentiation of these cells
by MyoD.
In fast-type muscles with large amounts of MyoD
[48,54], Myf-5 [48] and FGF6 (in the present study),
these proteins are favorably associated in muscle ¢-
ber in vivo. Furthermore, in vitro, RhoA GTPase
and serum response factor (SRF), a transcription
factor involved in activation of both mitogenic re-
sponse and muscle di¡erentiation [55], selectively
control the expression of MyoD [56], while the level
of the SRF protein is selectively distributed in the
fast-type muscle (unpublished data).
In vitro, motoneuron survival depended on vari-
ous neurotrophin, cytokine (LIF, glial cell line-de-
rived neurotrophic factor (GDNF), TGF-L and cil-
iary neurotrophic factors (CNTF)) as well as other
factors [57]. Neuronal injury increases retrograde
axonal transport of neurotrophin via binding to the
low-a⁄nity neurotrophin receptors or Trk receptors
[58] and those of the other cytokines, such as LIF
[59]. As demonstrated in this study, the LIF protein
was elevated in both the slow- and fast-type muscles
after cutting the sciatic nerve. This LIF induction is
important to inhibit motoneuron death and atrophy
of muscle ¢ber. LIF directly a¡ected the muscle ¢-
bers such that there was a signi¢cant increase in the
slow, and a reduction in the fast, muscle ¢ber diam-
eters in the LIF-treated group, compared to controls,
prior to reinnervation [60]. This selective attenuation
of ¢ber atrophy in the denervated slow-type muscle
was demonstrated by the injection of CNTF [61],
which like LIF, shared the gp130 signal-transducing
subunit as a common receptor component.
In conclusion, the preferential distribution of my-
ostatin and LIF was observed in slow-type muscles.
In contrast, the FGF6 protein was selectively ex-
pressed in fast-type muscles. The increased expres-
sion of myostatin and LIF plays an important role
in muscle hypertrophy due to mechanical overload-
ing. A marked reduction in FGF6 in hypertrophied
and regenerating muscles implies that FGF6 regu-
lates muscle di¡erentiation, but not proliferation, of
satellite cells and/or myoblasts.
Acknowledgements
This work was supported by Research Grants
10670775 and 11780059 from the Ministry of Educa-
tion, Science, and Culture of Japan.
References
[1] R. Bischo¡, in: A.G. Engel, C. Franzini-Armstrong (Eds.),
Myology, McGraw-Hill, New York, 1994, pp. 97^118.
[2] D.L. DeVol, P. Rotwein, J. Levis Sadow, J. Npvakofski, P.J.
Bechtel, Am. J. Physiol. 259 (1990) E89^E95.
[3] E. Jennische, G.L. Matejka, Acta Physiol. Scand. 146 (1992)
79^86.
[4] J.C. Engert, E.B. Berglund, N. Rosenthal, J. Cell Biol. 135
(1996) 431^440.
[5] M.E. Coleman, F. Demayo, K.C. Yin, H.M. Lee, R. Geske,
C. Montgomery, R.J. Schwartz, J. Biol. Chem. 270 (1995)
12109^12116.
[6] J. Baker, J.-P. Liu, E.J. Robertson, A. Efstradiadis, Cell 75
(1993) 73^82.
[7] C. Semsarian, M.-J. Wu, Y.-K. Ju, T. Marciniec, T. Yeoh,
D.G. Allen, R.P. Harvey, R.M. Graham, Nature 400 (1999)
576^581.
[8] A. Musaro¤, K.J.A. McCullagh, F.J. Naya, E.N. Olson, N.
Rosenthal, Nature 400 (1999) 581^585.
[9] C.H. Clegg, T.A. Linkhart, B.B. Olwin, S.D. Hauschka,
J. Cell Biol. 105 (1987) 949^956.
[10] T. Katagiri, S. Akiyama, M. Namiki, M. Komaki, A. Ya-
maguchi, V. Rosen, J.M. Wozney, A. Fujisawa-Sehara, T.
Suda, Exp. Cell Res. 230 (1997) 342^351.
[11] J. Massague¤, S. Cheifetz, T. Endo, B. Nadal-Ginard, Proc.
Natl. Acad. Sci. USA 83 (1986) 1799^1805.
[12] J.L. Escary, J. Perreau, D. Dumenil, S. Ezine, P. Brulet,
Nature 363 (1993) 361^364.
[13] A.B. Glick, M.M. Lee, N. Darwiche, A.B. Kulkarni, S.H.
Yuspa, Genes Dev. 8 (1994) 2429^2440.
[14] P. Lindahl, B.R. Johansson, P. Leveen, C. Betsholtz, Science
277 (1997) 242^245.
[15] Y. Taya, S. O’kane, M.W. Ferguson, Development 126
(1999) 3869^3879.
[16] J.B. Kurek, S. Nouri, G. Kannourakis, M. Murphy, A. Law-
rence, Muscle Nerve 19 (1996) 1291^1301.
[17] P. Mitchell, T. Steenstrup, K. Hannon, J. Appl. Physiol. 86
(1999) 313^319.
[18] K. Sakuma, K. Watanabe, T. Totsuka, I. Uramoto, M.
Sano, K. Sakamoto, Acta Neuropathol. 95 (1998) 123^
130.
[19] K. Sakuma, K. Watanabe, M. Sano, S. Kitajima, K. Saka-
BBAMCR 14632 22-5-00
K. Sakuma et al. / Biochimica et Biophysica Acta 1497 (2000) 77^88 87
moto, I. Uramoto, T. Totsuka, Acta Neuropathol. 99 (2000)
177^185.
[20] O. DeLapeyrie¤re, V. Ollendor¡, J. Planche, M.O. Ott, S.
Pizette, F. Coulier, D. Birnbaum, Development 118 (1993)
601^611.
[21] A.C. McPherron, A.M. Lawler, S.-J. Lee, Nature 387 (1997)
83^90.
[22] A.C. McPherron, S.-J. Lee, Proc. Natl. Acad. Sci. USA 94
(1997) 12457^12561.
[23] F. Fiore, J. Planche, P. Gibier, A. Sebille, O. DeLapeyrie¤re,
D. Birnbaum, Int. J. Dev. Biol. 41 (1997) 639^642.
[24] T. Floss, H.-H. Arnold, T. Braun, Genes Dev. 11 (1997)
2040^2051.
[25] E.C.B. Hall-Craggs, Exp. Neurol. 43 (1974) 349^358.
[26] K. Sakuma, A. Saitoh, S. Katsuta, Acta Neuropathol. 93
(1997) 129^135.
[27] U.K. Laemmli, Nature 227 (1970) 680^685.
[28] J.B. Peter, R.J. Barnard, V.R. Edgerton, C.A. Gillespie,
K.E. Stempel, Biochemistry 11 (1972) 2627^2633.
[29] P.D. Gollnick, D. Parsons, C.R. Oakley, Histochemistry 77
(1983) 543^555.
[30] N.F. Gonzalez-Cadavid, W.E. Taylor, K. Yarasheski, I.
Sinha-Hikim, K. Ma, S. Ezzat, R. Shen, R. Lalani, S. Asa,
M. Mamita, G. Nair, S. Arver, S. Bhasin, Proc. Natl. Acad.
Sci. USA 95 (1998) 14938^14943.
[31] A.J. Mason, P.G. Farnworth, J. Sullivan, Mol. Endocrinol.
10 (1996) 1055^1065.
[32] C.J. Carlson, F.W. Booth, S.E. Gordon, Am. J. Physiol. 277
(1999) R601^606.
[33] P.Y. Rescan, Biochim. Biophys. Acta 1443 (1998) 305^314.
[34] J.B. Kurek, L. Austin, S.S. Cheema, P.F. Bartlett, M. Mur-
phy, Neuromusc. Disord. 3 (1996) 463^469.
[35] J.B. Kurek, J.J. Bower, M. Romanella, F. Koentgen, M.
Murphy, L. Austin, Muscle Nerve 20 (1997) 815^822.
[36] M. Wehling, B. Cai, J.G. Tidball, FASEB J. 14 (2000) 103^
110.
[37] J.E. Anderson, L. Liu, E. Kardami, Dev. Biol. 147 (1991)
96^109.
[38] E. Schultz, K.C. Darr, in: D. Pette (Ed.), The Dynamic
State of Muscle ¢bers, de Gruyter, Berlin, 1990, pp. 667^679.
[39] J.S. Campbell, M.P. Wenderoth, S.D. Hauschka, E.G.
Krebs, Proc. Natl. Acad. Sci. USA 92 (1995) 870^874.
[40] L.A. Megeney, R.L. Perry, J.E. LeCouter, M.A. Rudnicki,
Dev. Genet. 19 (1996) 139^145.
[41] P.D. Gollnick, B.F. Timson, R.L. Moore, M. Riedy, J. Appl.
Physiol. 50 (1981) 936^943.
[42] R. Bischo¡, Development 109 (1990) 943^953.
[43] L. Grobet, L.J. Martin, D. Poncelet, D. Pirottin, B.
Brouwers, J. Riquet, A. Schoeberlein, S. Dunner, F. Menis-
sier, J. Massabanda, R. Fries, R. Hanset, M. Georges, Nat.
Genet. 17 (1997) 71^74.
[44] C. Semsarian, P. Sutrave, D.R. Richmond, R.M. Graham,
Biochem. J. 339 (1999) 443^451.
[45] L.A. Megeny, B. Kablar, K. Garrett, J.E. Anderson, M.A.
Rudnicki, Genes Dev. 10 (1996) 1173^1183.
[46] M.S. Clarke, D.L. Feeback, FASEB J. 10 (1996) 502^509.
[47] P.L. McNeil, R.A. Steinhardt, J. Cell Biol. 137 (1997) 1^
4.
[48] K. Sakuma, K. Watanabe, M. Sano, I. Uramoto, K. Saka-
moto, T. Totsuka, Biochim. Biophys. Acta 1428 (1999) 284^
292.
[49] S. Pizette, F. Coulier, D. Birnbaum, O. DeLapeyrie¤re, Exp.
Cell Res. 224 (1996) 143^151.
[50] K. Guo, J. Wang, V. Andres, R. Smith, K. Walsh, Mol. Cell.
Biol. 15 (1995) 3823^3829.
[51] P.L. Puri, M.L. Avantaggiati, C. Balsano, N. Sang, A.
Graessmann, A. Giordano, M. Levrero, EMBO J. 16
(1997) 369^383.
[52] K. Guo, K. Walsh, J. Biol. Chem. 272 (1997) 791^797.
[53] K. Walsh, H. Perlman, Curr. Opin. Genet. Dev. 7 (1997)
597^602.
[54] S.M. Hughes, K. Koishi, M. Rudnicki, A.M. Maggs, Mech.
Dev. 61 (1996) 151^163.
[55] C. Gauthier-Rouvie¤re, M. Vandromme, D. Tuil, N. Lautre-
dou, M. Morris, M. Soulez, A. Kahn, A. Fernandez, N.
Lamb, Mol. Cell. Biol. 5 (1996) 719^729.
[56] G. Carnac, M. Primig, M. Kitzmann, P. Chafey, D. Tuil, N.
Lamb, A. Fernandez, Mol. Biol. Cell 9 (1998) 1891^
1902.
[57] G. Terenghi, J. Anat. 194 (1999) 1^14.
[58] R. Curtis, J.R. Tonra, J.L. Stark, K.M. Adryan, J.S. Park,
K.D. Cli¡er, R.M. Lindsay, P.S. DiStefano, Mol. Cell. Neu-
rosci. 12 (1998) 105^118.
[59] R. Curtis, S.S. Scherer, R. Somogyi, K.M. Adryan, N.Y. Ip,
Y. Zhu, R.M. Lindsay, P.S. DiStefano, Neuron 12 (1994)
191^204.
[60] S. Tham, B. Dowsing, D. Finkelstein, R. Donato, S.S. Chee-
ma, P. Bartlett, W.A. Morrison, J. Neurosci. Res. 47 (1997)
208^215.
[61] M.E. Helgren, S.P. Squinto, H.L. Davis, D.J. Parry, T.G.
Boulton, C.S. Heck, Y. Zhu, G.D. Yancopoulos, R.M.
Lindsay, P.S. DiStefano, Cell 76 (1994) 493^504.
BBAMCR 14632 22-5-00
K. Sakuma et al. / Biochimica et Biophysica Acta 1497 (2000) 77^8888
